Salicylic acid: A link between aspirin, diet and the prevention of colorectal cancer

QJM: An International Journal of Medicine

Volumn 94, Issue 8, 2001, Pages 445-448

  Paterson, J R ^a   Lawrence, J R ^a  

^a DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DRUG METABOLITE; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER PREVENTION; CANCER RISK; CLINICAL PRACTICE; COLORECTAL CANCER; DIET; DRUG BLOOD LEVEL; FRUIT; HUMAN; PLANT; PRIORITY JOURNAL; VEGETARIAN;

EID: 0034892506     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/94.8.445     Document Type: Article

References (37)

1. Aspirin use and risk of fatal cancer
2. Reduced incidence of colorectal adenoma among long-term users of non-steroidal antiinflammatory drugs: A pooled analysis of published studies and a new population-based study
3. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs
4. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis
5. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats
6. Clinical pharmacokinetics of the salicylates
7. Salicylic acid in strawberries
8. 'Natural' and synthetic salicylates
9. Plants just say NO to pathogens
10. Salicylic acid in fresh and canned fruit and vegetables
11. Determination of acetylsalicylic and salicylic acid in foods, using HPLC with fluorescence detection
12. Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in foods are low
13. Suppression of human colorectal mucosal prostaglandins: Determining the lowest effective aspirin dose
14. The identification of salicylates as normal constituents of serum: A link between diet and health?
15. Salicylic acid concentrations in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians and patients taking low-dose aspirin
16. Inflammation and cancer: Back to Virchow?
17. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
18. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease
19. Host cyclooxygenase-2 modulates carcinoma growth
20. Chemoprevention of colorectal cancer
21. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and anti-inflammatory activity
22. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
23. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells
24. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
25. Salicylic acid and disease resistance in plants
26. A molecular biological basis for the nutritional and pharmacological benefits of dietary plants
27. Aspirin and salicylate. An old remedy with a new twist
28. Cyclooxygenase-2, non-steroidal anti-inflammatory drugs and cancer of the esophagus
29. Expression of cyclooxygenase-2 in human gastric carcinoma
30. Cyclooxygenase-2 induction in congestive heart failure. Friend or foe
31. Atherosclerosis: An inflammatory disease
32. Beyond willow bark: Aspirin in the prevention of chronic disease
33. Effect of aspirin on prostaglandin E2 formation and transforming growth factor α expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon
34. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal and rectal prostaglandin levels and on mucosal injury in healthy humans
35. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients
36. Aspirin use and colorectal cancer: Post-trial follow-up data from the physicians' health study